Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Apotea
UN
Unike
Community Contributor
Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions
Catalysts Most Immediate Catalysts (1–2 Years) Online Pharmacy Market Growth: The Swedish pharmacy market is shifting online, benefiting Apotea as the dominant e-commerce player. Consumers increasingly prefer digital purchases over physical store visits.
View narrative
SEK 94.41
FV
18.4% overvalued
intrinsic discount
7.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 months ago
author updated this narrative
Cybin
ZI
Zip2420
Community Contributor
Cybin Set to Revolutionize Psychedelic Therapy with CYB003's Promising Results
It sounds like Cybin (CYBN) is gaining serious traction in the psychedelic therapy space! Guggenheim’s $35 price target is pretty aggressive, considering the stock is currently trading at a fraction of that.
View narrative
CA$0
FV
90.5% undervalued
intrinsic discount
87.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 months ago
author updated this narrative
Samhällsbyggnadsbolaget i Norden
IN
InvestorSE
Community Contributor
Undervalued - Price Target SEK 6.50
Samhällsbyggnadsbolaget i Norden AB (SBB) has recently released its Q4 2024 financial report , signaling strong improvements in its financial position and confirming its ability to navigate challenging market conditions. The company reported a pre-tax loss of SEK 613 million , a significant reduction from the SEK 3.37 billion loss in the same period of 2023.
View narrative
SEK 6.50
FV
25.1% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
6 months ago
author updated this narrative
Micron Technology
73
73Skip
Community Contributor
Micron will be one of the biggest beneficiaries in the semiconductor industry of the multi-year growth opportunity driven by AI
Catalysts With the advancement of AI there will be high demand for High Bandwidth Memory (HBM) devices for AI data centres. Micron are in a strong position to serve AI demand for fast storage as these data-intensive applications proliferate.
View narrative
US$159.75
FV
22.7% undervalued
intrinsic discount
26.00%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
4
users have commented on this narrative
52
users have followed this narrative
12 months ago
author updated this narrative
Samaiden Group Berhad
ON
Ontological
Community Contributor
Sunshine Powers More Than Plants-Samaiden
Renewable Energy in Malaysia and ASEAN Region Catalysts 1. Samaiden (KLSE: 0223) is an engineering, procurement, construction and commissioning (EPCC) company of solar photovoltaic systems and power plants in Malaysia.
View narrative
RM 1.81
FV
35.9% undervalued
intrinsic discount
25.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 months ago
author updated this narrative
Boeing
FR
FrugalBull
Community Contributor
A Turnaround Taking Flight on Commercial Recovery and Operational Execution
Drivers of Growth and Valuation Commercial Aviation Recovery: Global air travel demand has rebounded to pre-pandemic levels and continues to grow. Airlines are rebuilding and expanding fleets, fueling large aircraft orders.
View narrative
US$206.79
FV
12.4% overvalued
intrinsic discount
15.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
6 months ago
author updated this narrative
SHIP
Tufton Assets
ZE
zeg0at
Community Contributor
Tufton Assets: High-Yield, Deep-Value Shipping with a Built-In Exit 28% NAV Discount
Executive Summary Tufton Assets Limited (LSE: SHPP) presents a rare and compelling opportunity in public markets: a high-yield, NAV-discounted, actively managed vehicle with a clearly defined end-of-life wind-down strategy. The company's structure, execution history, and exposure to shipping segments aligned with geopolitical and macroeconomic dislocation make it uniquely suited for investors seeking inflation-protected income, asymmetric upside from trade realignments, and built-in downside mitigation through real asset monetization.
View narrative
US$1.40
FV
18.9% undervalued
intrinsic discount
20.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
3
users have followed this narrative
3 months ago
author updated this narrative
GeoPark
WA
WaneInvestmentHouse
Community Contributor
GeoPark Limited's Share Price Drops 43% in Three Years: A Disparity Between Shareholder Returns and Business Performance?
GeoPark Limited (NYSE:GPRK) has experienced a decline in its share price, dropping 43% over three years, despite a market return of about 37%. This underwhelming performance has left long-term shareholders disappointed.
View narrative
US$7.93
FV
16.1% undervalued
intrinsic discount
4.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
1
users have followed this narrative
5 months ago
author updated this narrative
1830
Perfect Medical Health Management
LA
Lahmstanley
Community Contributor
Good Prospects if management is strategic. Fair value between 4 - 9 HKD.
Summary Estimated Liquidating Value - March 2024 - 0.16 HKD Business Value Range 4 - 9 HKD. Dividend Record - 11 years uninterrupted.
View narrative
HK$9.00
FV
82.6% undervalued
intrinsic discount
37.76%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
about 1 year ago
author updated this narrative
Value any company in seconds
Popular companies